Literature DB >> 12432568

Role of ICOS versus CD28 in antiviral immunity.

Edward M Bertram1, Anna Tafuri, Arda Shahinian, Vera S F Chan, Lukas Hunziker, Mike Recher, Pamela S Ohashi, Tak W Mak, Tania H Watts.   

Abstract

The costimulatory protein ICOS is inducibly expressed on activated T cells. Previous results have shown that ICOS(-/-) mice are defective in germinal center formation, antibody (Ab) production and class switch as well as Th1 and Th2 cytokine production in response to protein or parasite antigens. However, ICOS-Ig failed to block antiviral Ab responses. To date the immune response to viruses has not been examined in ICOS(-/-) mice. In this report we compared antiviral Ab responses to LCMV, VSV and influenza virus in ICOS(-/-) versus wild-type mice. Our results show that ICOS is important in the Ab response to all three viruses, with greater effects on primary as compared to secondary responses. Although ICOS(-/-) mice are impaired in some immune responses following influenza infection, the effects were less severe than for CD28(-/-) mice. There was no defect in initial influenza-specific CD8 T cell expansion in ICOS(-/-) mice or in cytotoxic effector function. However, ICOS was important in maintaining CD4 cytokine production and CD8 T cell numbers late in the primary response. Upon secondary infection, ICOS(-/-) mice show wild-type levels of influenza-specific CD8 T cells, whereas CD28(-/-) mice show greatly impaired secondary CD8 T cell expansion. Overall, our results show that ICOS plays a clear role in the primary response to viruses at the level of Ab production, germinal center formation and Th cytokine production, but has diminished effects following secondary viral challenge.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12432568     DOI: 10.1002/1521-4141(200212)32:12<3376::AID-IMMU3376>3.0.CO;2-Y

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  41 in total

1.  Detailed analysis of the CD8+ T-cell response following adenovirus vaccination.

Authors:  Teng Chih Yang; Kelley Dayball; Yong Hong Wan; Jonathan Bramson
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

2.  Viral Persistence Induces Antibody Inflation without Altering Antibody Avidity.

Authors:  Suzanne P M Welten; Anke Redeker; René E M Toes; Ramon Arens
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

3.  CD80 and CD86 control antiviral CD8+ T-cell function and immune surveillance of murine gammaherpesvirus 68.

Authors:  Shinichiro Fuse; Joshua J Obar; Sarah Bellfy; Erica K Leung; Weijun Zhang; Edward J Usherwood
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

4.  T-cell tolerance or function is determined by combinatorial costimulatory signals.

Authors:  Roza Nurieva; Sunil Thomas; Thang Nguyen; Natalia Martin-Orozco; Ying Wang; Murali-Krishna Kaja; Xue-Zhong Yu; Chen Dong
Journal:  EMBO J       Date:  2006-05-25       Impact factor: 11.598

Review 5.  Approaches to studying costimulation of human antiviral T cell responses: prospects for immunotherapeutic vaccines.

Authors:  Lena Serghides; Mariana Vidric; Tania H Watts
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

6.  T cell costimulatory molecules in anti-viral immunity: Potential role in immunotherapeutic vaccines.

Authors:  Tania H Watts; Edward M Bertram; Jacob Bukczynski; Tao Wen
Journal:  Can J Infect Dis       Date:  2003-07

7.  Differential requirements for CD80/86-CD28 costimulation in primary and memory CD4 T cell responses to vaccinia virus.

Authors:  Shinichiro Fuse; Ching-Yi Tsai; Leah M Rommereim; Weijun Zhang; Edward J Usherwood
Journal:  Cell Immunol       Date:  2010-10-30       Impact factor: 4.868

8.  CD4+-T-cell effector functions and costimulatory requirements essential for surviving mucosal infection with Citrobacter rodentium.

Authors:  Lynn Bry; Manfred Brigl; Michael B Brenner
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

9.  Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells.

Authors:  Shahram Salek-Ardakani; Ramon Arens; Rachel Flynn; Alessandro Sette; Stephen P Schoenberger; Michael Croft
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

Review 10.  Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease.

Authors:  John Attanasio; E John Wherry
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.